close

Fredun Pharmaceuticals Ltd

Know More
NSEBSE
Stock not tradded

871.00-7.00 (-0.80%)

04:01 PM,26th Sep 2023

BSE : 539730

NSE :

Sector : Health care

ISIN Code : INE194R01017

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Sep 26 2023 | 04:01 PM IST

Market Cap (₹ Cr)

0

Turnover (₹ Cr)

0.00

Volume (Shares)

Face Value

10

52-WK High

0.00

52-WK High Date

Invalid date

52-WK Low

0.00

52-WK Low Date

Invalid date

All Time High

0.00

All Time High Date

Invalid date

All Time Low

0.00

All Time Low Date

Invalid date

Fredun Pharmaceuticals Ltd

Incorported in 1987 as a private limited company Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.'94. It was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma a proprietory firm for the manufacture and export of pharmaceutical formulations. The exports were mainly to Afghanistan and west Africa. Since 1993 D N Pharma's operations were phased out in order to switch over the business to FPL. FPL was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets capsules dry-syrups and ointments. It then set up a formulation unit at Palghar (Thane district) Maharashtra which commenced commercial production in Aug.'94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters including Merind.In Apr.'96 the company came out with a public issue to register its products in the overseas market for exports; to part-finance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden. Company is very much optimistic of revival of company's turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal Tanzaniya Uganda & Sri Lanka.

Fredun Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

398

EPS - TTM (₹) [S]

28.17

P/E Ratio (X) [S]

4.30

Face Value (₹) 10
Latest Dividend (%)7.00
Latest Dividend Date 22 Sep 2023
Dividend Yield (%) 0.08
Book Value Share (₹) [S]202.65
P/B Ratio (₹) [S]4.30
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

865.00

893.50

Week Low/High

855.00

932.00

Month Low/High

846.00

1000.00

Year Low/High

740.00

1428.00

All time Low/High

12.50

1428.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-4.37%%-2.44-1.17%
1 Month-10.19%%1.632.09%
3 Month5.32%%4.734.52%
6 Month3.19%%14.6315.79%
1 Year-16.96%%15.4015.64%
3 Year275.84%%76.3877.99%

Financials

Graph
Table

Bulk/ Block

ALL
NSE
BSE
ALL
BUY
SELL
DateClient NameExchangeTransactionQuantityPrice
14-09-2021ANAND JHINGANBSESELL24758422.48
14-09-2021ASHOK JHINGANBSESELL24000443.07
01-07-2020KAMAL KUMAR JALAN SEC. PVT. LTDBSEBUY33872184.83
01-07-2020KAMAL KUMAR JALAN SEC. PVT. LTDBSESELL33697187.30
01-07-2020SURINDER GURMUKH DHAULBSEBUY24881183.48
01-07-2020SURINDER GURMUKH DHAULBSESELL24881186.19
01-07-2020ZAHEER .BSEBUY112025186.01
01-07-2020ZAHEER .BSESELL112025183.28
15-01-2018MADHUBALA PARESH TRIVEDIBSESELL15400142.70

Peer Group Comparison

NamePrice(In Rs)Chg(%)Mkt Cap(Rs Cr)Sales(Rs Cr)Profit(Rs Cr)EPS(Rs)P/E(x)

Shareholding Pattern

Jun 2023
Archive
CategoryShare(%)
Promoter49.11
Financial Institutions Banks1.61
Foreign Institutional Investors0.00
Insurance Companies0.00
Mutual Funds Uti0.00
Other Institutional Investors0.00
Indian Public43.73
Others Non Institutional Investors5.56
Custodians0.00

Corporate Action

Announcement DatePurposeFromToRemarks
Data Not Found

Price History

Search for Price History

DateOpenHighLowCloseSharesTrades
Data Not Found

Load more

Company Info

Company Information

Chairperson & Joint MD : Daulat N Medhora

Executive Director : Nariman B Medhora

Non-Exec. & Independent Dir. : Aspi N Raimalwala

Managing Director & CFO : Fredun N Medhora

Non-Exec. & Independent Dir. : Rohinton Kanga

Company Sec. & Compli. Officer : Jinkal Shah

Registered Office: 26 Manoj Industrial Premises, G D Ambedkar Marg Wadala,Mumbai,Maharashtra-400031 Ph: 91-22-40318111

Email:business@fredungroup.com

URL:http://www.fredungroup.com